In this regard, VEGFB’s involvement in lipid metabolism and its regulation of mitochondrial dynamics provide new insights into its therapeutic potential in addressing metabolic dysfunctions, in particular ferroptosis induction in MI, that often accompany cardiovascular diseases [61]. The gene discussed is VEGFB; the disease is cardiovascular disorder.